{"nct_id":"NCT02218697","title":"Evaluation of the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine Influsplit™ Tetra (Fluarix™ Tetra) (GSK2321138A) When Co-administered With Pneumovax™ 23 in Adults 50 Years of Age and Older","status":"COMPLETED","status_verified_date":"2018-03","start_date":"2014-10-01","start_date_type":"ACTUAL","primary_completion_date":"2015-01-14","primary_completion_date_type":"ACTUAL","completion_date":"2015-05-04","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}